...
首页> 外文期刊>Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis >Analysis of non enzymatic glycosylation in vivo: impact of different dialysis solutions.
【24h】

Analysis of non enzymatic glycosylation in vivo: impact of different dialysis solutions.

机译:体内非酶糖基化分析:不同透析液的影响。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Glucose-containing dialysis solutions in peritoneal dialysis (PD) patients induce non enzymatic glycosylation (NEG) within the peritoneal cavity.The subsequent formation of advanced glycosylation end-products (AGEs) may be implicated in the functional deterioration of the peritoneal membrane in long-term PD patients. AIM OF THE STUDY AND PARAMETERS: Measurement of NEG by the determination of percent glycation of albumin and IgG (GP), and of AGEs by measuring pentosidine content of protein in 4-hour effluents (Peff) and serum. SUBJECTS: In 5 patients each, a comparison was made between 3.86% glucose and 1.36% glucose (GP and Peff), and between 3.86% glucose and 7.5% icodextrin (Peff). Nine patients with clinically severe ultrafiltration failure (UFF) were compared to nine patients treated with PD for 1 month. Six of the patients with UFF were treated with non glucose dialysis solutions and Peff was studied again after 6 weeks. RESULTS: No difference was found between Peff comparing 3.86% glucose to either 1.36% glucose or icodextrin. GP were higher in 3.86% glucose than in 1.36%. Glycatedon glycated (G/NG) protein clearance ratios were 1.29 for albumin and 1.12 for IgG (p = 0.003). In contrast to GP, both Peff and serum pentosidine were higher in the UFF patients than in the recently started patients. Peff, but not GP, correlated with duration of PD (r = 0.67, p = 0.04). In 5 of 6 patients treated with non glucose dialysate, Peff decreased while serum pentosidine was stable. DISCUSSION: These data show that 4-hour Peff contents are not influenced by glucose concentration or osmolality, in contrast to GP. The relation between Peff and duration of PD, and the effect of non glucose dialysate on Peff, suggest that long-term glucose exposure is an important determinant of membrane glycosylation. Thus Peff probably reflects the long-term effects of intraperitoneal glycosylation of peritoneal membrane proteins. Treatment with non glucose dialysis solutions may result in "washout" of glycosylated proteins from the peritoneal membrane.
机译:背景:腹膜透析(PD)患者中的含糖透析液会在腹膜腔内诱导非酶促糖基化(NEG),随后形成的高级糖基化终产物(AGEs)可能与腹膜透析的功能有关。长期PD患者。研究和参数的目的:通过测定白蛋白和IgG(GP)的糖基化百分比来测定NEG,并通过测量4小时出水(Peff)和血清中戊糖苷的含量来测定AGEs。研究对象:在5位患者中,分别对3.86%葡萄糖和1.36%葡萄糖(GP和Peff)以及3.86%葡萄糖和7.5%艾考糊精(Peff)进行了比较。将9例临床严重超滤失败(UFF)的患者与9例接受PD治疗1个月的患者进行比较。 UFF患者中有6名接受了非葡萄糖透析液治疗,并且在6周后再次研究了Peff。结果:Peff比较3.86%葡萄糖与1.36%葡萄糖或艾考糊精之间没有差异。葡萄糖中3.86%的GP高于1.36%的GP。糖化/非糖化(G / NG)蛋白清除率,白蛋白为1.29,IgG为1.12(p = 0.003)。与GP相反,UFF患者的Peff和血清戊糖苷均高于刚开始接受治疗的患者。 Peff而非PD与PD的持续时间相关(r = 0.67,p = 0.04)。在使用非葡萄糖透析液治疗的6例患者中,有5例的Peff降低而血清戊糖苷稳定。讨论:这些数据表明,与GP相比,4小时Peff含量不受葡萄糖浓度或重量克分子渗透压浓度的影响。 Peff与PD持续时间之间的关系以及非葡萄糖透析液对Peff的影响表明,长期暴露于葡萄糖是膜糖基化的重要决定因素。因此,Peff可能反映了腹膜内腹膜蛋白的腹膜内糖基化的长期作用。用非葡萄糖透析溶液处理可能会导致腹膜上的糖基化蛋白被“冲洗掉”。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号